Greg and Matias chat with Brooks about the evolution of PsyMed Ventures’ investment strategy: a human-first approach to neurotech, novel therapeutics, consumer health, and precision neuroscience
Love seeing PsyMed Ventures championing a human first approach in neurotech finally shifting the paradigm away from mouse models to real world patient data.
Curious to hear your thoughts on how consumer health wearables might integrate with AI enabled care platforms to create more personalized, preventive brain health solutions.
Love seeing PsyMed Ventures championing a human first approach in neurotech finally shifting the paradigm away from mouse models to real world patient data.
Curious to hear your thoughts on how consumer health wearables might integrate with AI enabled care platforms to create more personalized, preventive brain health solutions.